Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 5;49(6):406-407.
doi: 10.1159/000526176. eCollection 2022 Dec.

Reply to the Letter-to-the-Editor Comment to Moog et al.: Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study

Rainer Moog  1 , Teija Dehmer-Laitinen  1 , Uwe Taborski  1
Affiliations

Reply to the Letter-to-the-Editor Comment to Moog et al.: Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study

Rainer Moog et al. Transfus Med Hemother. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors are employees at Octapharma Plasma GmbH.

References

    1. Preußel K, Offergeld R. Letter to the editor: safety of plasmapheresis in donors with low IgG levels: results of a prospective, controlled multicentre study. Transfus Med Hemother. 2022 Epub ahead of print. - PMC - PubMed
    1. Moog R, Laitinen T, Taborski U. Safety of plasmapheresis in donors with low IgG levels: results of a prospective, controlled multicentre study. Transfus Med Hemother. 2022 Epub ahead of print. - PMC - PubMed
    1. Schulzki T, Seidel K, Storch HKH, Karges H, Kiessig S, Schneider S, et al. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA) Vox Sang. 2006;91((2)):162–73. - PubMed
    1. Bechtloff S, Tran-My B, Haubelt H, Stelzer G, Anders C, Hellstern P. A prospective trial on the safety of long-term intensive plasmapheresis in donors. Vox Sang. 2005;88((3)):189–95. - PubMed
    1. Taborski U, Laitinen T. Donor safety in an individualized plasmapheresis program: results of an interim analysis. Transfus Apher Sci. 2022 Epub ahead of print. - PubMed